Review





Similar Products

a549-hace2-tmprss2 cells  (InvivoGen)
95
InvivoGen a549-hace2-tmprss2 cells
A549 Hace2 Tmprss2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/A549-hACE2-TMPRSS2+Cells/custom%40a549-hace2tpsa%4010%2E64898%2F2026%2E09%2E07%2E749787
Average 95 stars, based on 1 article reviews
a549-hace2-tmprss2 cells - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
bhk21 hace2 cells 、 h1299 cells 、 hek293t cells  (ATCC)
99
ATCC bhk21 hace2 cells 、 h1299 cells 、 hek293t cells
Bhk21 Hace2 Cells 、 H1299 Cells 、 Hek293t Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/BHK-21/pm42319828-226-1-10
Average 99 stars, based on 1 article reviews
bhk21 hace2 cells 、 h1299 cells 、 hek293t cells - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
male transgenic k18 hace2 mice  (Jackson Laboratory)
86
Jackson Laboratory male transgenic k18 hace2 mice
Male Transgenic K18 Hace2 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/hace2+k18+mice/pm42288894-93-0-32
Average 86 stars, based on 1 article reviews
male transgenic k18 hace2 mice - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
a549-dual hace2-tmprss2 cells  (InvivoGen)
95
InvivoGen a549-dual hace2-tmprss2 cells
A549 Dual Hace2 Tmprss2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/A549-Dual+hACE2-TMPRSS2+Cells/custom%40a549d-cov2r%4042160828
Average 95 stars, based on 1 article reviews
a549-dual hace2-tmprss2 cells - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
k18 hace2 transgenic mice  (Jackson Laboratory)
86
Jackson Laboratory k18 hace2 transgenic mice
(A) Design and execution of an immunogen efficacy experiment to test the longevity of protection against SARS-CoV-2 variants that might emerge after immunization. Mice received two doses of immunogen, and were challenged one year later with whatever SARS-CoV-2 variant was prevalent one year after the design of the immunogen. (B-F) Neutralizing titers (NT 50 ) over time (up to 1 year) against SARS-CoV-2 Wu , SARS-CoV-2 XBB, SARS-CoV-2 KP2/3 pseudotypes in mouse sera after immunization with two doses of the indicated immunogens. Graph title indicates immunogen, each line represents 1 mouse, n = 6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (G) SARS-CoV-2 KP.3.1 lung viral loads on day 3 after infection <t>of</t> <t>K18-hACE2</t> mice, immunized one year previously with two doses of indicated immunogen. Each symbol represents mean of measurements from the left lung and right lung of each mouse, black line = group median. Dotted line indicates limit of detection. (H) Lung viral loads (rVSV/SARS-1 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 IFNAR(-/-) mice, immunized 12 weeks prior with two doses of indicated immunogen. Each symbol represents one mouse lung, each line represents group median. Dotted line indicates limit of detection.
K18 Hace2 Transgenic Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/hace2+k18+mice/bio_rxiv__64898__2026__06__03__729821-232-36-32
Average 86 stars, based on 1 article reviews
k18 hace2 transgenic mice - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
k18 hace2 2prlmn j  (Jackson Laboratory)
86
Jackson Laboratory k18 hace2 2prlmn j
(A) Design and execution of an immunogen efficacy experiment to test the longevity of protection against SARS-CoV-2 variants that might emerge after immunization. Mice received two doses of immunogen, and were challenged one year later with whatever SARS-CoV-2 variant was prevalent one year after the design of the immunogen. (B-F) Neutralizing titers (NT 50 ) over time (up to 1 year) against SARS-CoV-2 Wu , SARS-CoV-2 XBB, SARS-CoV-2 KP2/3 pseudotypes in mouse sera after immunization with two doses of the indicated immunogens. Graph title indicates immunogen, each line represents 1 mouse, n = 6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (G) SARS-CoV-2 KP.3.1 lung viral loads on day 3 after infection <t>of</t> <t>K18-hACE2</t> mice, immunized one year previously with two doses of indicated immunogen. Each symbol represents mean of measurements from the left lung and right lung of each mouse, black line = group median. Dotted line indicates limit of detection. (H) Lung viral loads (rVSV/SARS-1 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 IFNAR(-/-) mice, immunized 12 weeks prior with two doses of indicated immunogen. Each symbol represents one mouse lung, each line represents group median. Dotted line indicates limit of detection.
K18 Hace2 2prlmn J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/hace2+k18+mice/pm42259181-42-1-2
Average 86 stars, based on 1 article reviews
k18 hace2 2prlmn j - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
hace2  (ATCC)
99
ATCC hace2
(A) Design and execution of an immunogen efficacy experiment to test the longevity of protection against SARS-CoV-2 variants that might emerge after immunization. Mice received two doses of immunogen, and were challenged one year later with whatever SARS-CoV-2 variant was prevalent one year after the design of the immunogen. (B-F) Neutralizing titers (NT 50 ) over time (up to 1 year) against SARS-CoV-2 Wu , SARS-CoV-2 XBB, SARS-CoV-2 KP2/3 pseudotypes in mouse sera after immunization with two doses of the indicated immunogens. Graph title indicates immunogen, each line represents 1 mouse, n = 6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (G) SARS-CoV-2 KP.3.1 lung viral loads on day 3 after infection <t>of</t> <t>K18-hACE2</t> mice, immunized one year previously with two doses of indicated immunogen. Each symbol represents mean of measurements from the left lung and right lung of each mouse, black line = group median. Dotted line indicates limit of detection. (H) Lung viral loads (rVSV/SARS-1 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 IFNAR(-/-) mice, immunized 12 weeks prior with two doses of indicated immunogen. Each symbol represents one mouse lung, each line represents group median. Dotted line indicates limit of detection.
Hace2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/HeLa/pm42241278-654-10-14
Average 99 stars, based on 1 article reviews
hace2 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
k18 hace2 mice  (Jackson Laboratory)
86
Jackson Laboratory k18 hace2 mice
(A) Design and execution of an immunogen efficacy experiment to test the longevity of protection against SARS-CoV-2 variants that might emerge after immunization. Mice received two doses of immunogen, and were challenged one year later with whatever SARS-CoV-2 variant was prevalent one year after the design of the immunogen. (B-F) Neutralizing titers (NT 50 ) over time (up to 1 year) against SARS-CoV-2 Wu , SARS-CoV-2 XBB, SARS-CoV-2 KP2/3 pseudotypes in mouse sera after immunization with two doses of the indicated immunogens. Graph title indicates immunogen, each line represents 1 mouse, n = 6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (G) SARS-CoV-2 KP.3.1 lung viral loads on day 3 after infection <t>of</t> <t>K18-hACE2</t> mice, immunized one year previously with two doses of indicated immunogen. Each symbol represents mean of measurements from the left lung and right lung of each mouse, black line = group median. Dotted line indicates limit of detection. (H) Lung viral loads (rVSV/SARS-1 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 IFNAR(-/-) mice, immunized 12 weeks prior with two doses of indicated immunogen. Each symbol represents one mouse lung, each line represents group median. Dotted line indicates limit of detection.
K18 Hace2 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hace2/hace2+k18+mice/pm42174265-230-11-18
Average 86 stars, based on 1 article reviews
k18 hace2 mice - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


(A) Design and execution of an immunogen efficacy experiment to test the longevity of protection against SARS-CoV-2 variants that might emerge after immunization. Mice received two doses of immunogen, and were challenged one year later with whatever SARS-CoV-2 variant was prevalent one year after the design of the immunogen. (B-F) Neutralizing titers (NT 50 ) over time (up to 1 year) against SARS-CoV-2 Wu , SARS-CoV-2 XBB, SARS-CoV-2 KP2/3 pseudotypes in mouse sera after immunization with two doses of the indicated immunogens. Graph title indicates immunogen, each line represents 1 mouse, n = 6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (G) SARS-CoV-2 KP.3.1 lung viral loads on day 3 after infection of K18-hACE2 mice, immunized one year previously with two doses of indicated immunogen. Each symbol represents mean of measurements from the left lung and right lung of each mouse, black line = group median. Dotted line indicates limit of detection. (H) Lung viral loads (rVSV/SARS-1 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 IFNAR(-/-) mice, immunized 12 weeks prior with two doses of indicated immunogen. Each symbol represents one mouse lung, each line represents group median. Dotted line indicates limit of detection.

Journal: bioRxiv

Article Title: A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization

doi: 10.64898/2026.06.03.729821

Figure Lengend Snippet: (A) Design and execution of an immunogen efficacy experiment to test the longevity of protection against SARS-CoV-2 variants that might emerge after immunization. Mice received two doses of immunogen, and were challenged one year later with whatever SARS-CoV-2 variant was prevalent one year after the design of the immunogen. (B-F) Neutralizing titers (NT 50 ) over time (up to 1 year) against SARS-CoV-2 Wu , SARS-CoV-2 XBB, SARS-CoV-2 KP2/3 pseudotypes in mouse sera after immunization with two doses of the indicated immunogens. Graph title indicates immunogen, each line represents 1 mouse, n = 6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (G) SARS-CoV-2 KP.3.1 lung viral loads on day 3 after infection of K18-hACE2 mice, immunized one year previously with two doses of indicated immunogen. Each symbol represents mean of measurements from the left lung and right lung of each mouse, black line = group median. Dotted line indicates limit of detection. (H) Lung viral loads (rVSV/SARS-1 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 IFNAR(-/-) mice, immunized 12 weeks prior with two doses of indicated immunogen. Each symbol represents one mouse lung, each line represents group median. Dotted line indicates limit of detection.

Article Snippet: All mouse studies were performed in compliance with the Rockefeller University Institutional Animal Care and Use Committee (IACUC) according to animal protocol 24016-H. For analysis of neutralizing antibody responses, ten-week old C57BL/6 (JAX Strain #000664) and K18-hACE2 transgenic mice expressing the human ACE [B6.

Techniques: Variant Assay, Infection

(A,B) Comparison of neutralizing titers (NT 50 ) against SARS-CoV-2 variant pseudotypes in mouse sera 12 and 51 weeks post-immunization with two doses of indicated immunogen. Each symbol represents 1 mouse, lines = group mean, n = 5-6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (C) Validation of SARS-CoV-2 challenge virus stocks, KP.3 and KP.3.1. Lung viral loads (SARS-CoV-2 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 mice. Each symbol represents 1 mouse, lines = group geometric mean, n=5 mice per group (D) Lung viral loads (rVSV/SARS-1 RNA copies per μg total lung RNA) on each of the indicated hours after infection of K18-hACE2 IFNAR(-/-) mice. Each symbol represents 1 mouse, dotted line=limit of detection.

Journal: bioRxiv

Article Title: A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization

doi: 10.64898/2026.06.03.729821

Figure Lengend Snippet: (A,B) Comparison of neutralizing titers (NT 50 ) against SARS-CoV-2 variant pseudotypes in mouse sera 12 and 51 weeks post-immunization with two doses of indicated immunogen. Each symbol represents 1 mouse, lines = group mean, n = 5-6 mice per group. Dotted line indicates the lowest sera dilution tested (1:50). (C) Validation of SARS-CoV-2 challenge virus stocks, KP.3 and KP.3.1. Lung viral loads (SARS-CoV-2 RNA copies per μg total RNA) on day 3 after infection of K18-hACE2 mice. Each symbol represents 1 mouse, lines = group geometric mean, n=5 mice per group (D) Lung viral loads (rVSV/SARS-1 RNA copies per μg total lung RNA) on each of the indicated hours after infection of K18-hACE2 IFNAR(-/-) mice. Each symbol represents 1 mouse, dotted line=limit of detection.

Article Snippet: All mouse studies were performed in compliance with the Rockefeller University Institutional Animal Care and Use Committee (IACUC) according to animal protocol 24016-H. For analysis of neutralizing antibody responses, ten-week old C57BL/6 (JAX Strain #000664) and K18-hACE2 transgenic mice expressing the human ACE [B6.

Techniques: Comparison, Variant Assay, Biomarker Discovery, Virus, Infection